Treatment of 5/6 nephrectomy rats with sulodexide: a novel therapy for chronic renal failure (Q33567365)

28 July 2017

title

Treatment of 5/6 nephrectomy rats with sulodexide: a novel therapy for chronic renal failure (English)

1 reference

28 July 2017

Ping Li

1

1 reference

28 July 2017

Lin-lin Ma

2

1 reference

28 July 2017

Ru-juan Xie

3

1 reference

28 July 2017

Yuan-sheng Xie

4

1 reference

28 July 2017

Ri-bao Wei

5

1 reference

28 July 2017

Min Yin

6

1 reference

28 July 2017

Jian-zhong Wang

7

1 reference

28 July 2017

Xiang-mei Chen

8

1 reference

28 July 2017

publication date

1 May 2012

1 reference

Acta Pharmacologica Sinica

28 July 2017

published in

1 reference

28 July 2017

volume

33

1 reference

28 July 2017

issue

5

1 reference

28 July 2017

page(s)

644-651

1 reference

Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4010349

Progress Toward Novel Treatments for Chronic Kidney Disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4010349

The role of sulodexide in the treatment of diabetic nephropathy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4010349

One year course of oral sulodexide in the management of diabetic nephropathy.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4010349

Prevention of progression and remission/regression strategies for chronic renal diseases: can we do better now than five years ago?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4010349

Role of the microvascular endothelium in progressive renal disease.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4010349

Review of pharmacodynamics, pharmacokinetics, and therapeutic properties of sulodexide

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4010349

Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial

21 June 2018

1 reference

https://api.crossref.org/works/10.1038%2FAPS.2012.2

A role for uric acid in the progression of renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAPS.2012.2

Calcium citrate ameliorates the progression of chronic renal injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAPS.2012.2

A study on the safety, efficacy, and efficiency of sulodexide compared with acenocoumarol in secondary prophylaxis in patients with deep venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAPS.2012.2

Anti-inflammatory effect of sulodexide during acute peritonitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAPS.2012.2

Effects of sulodexide in patients with type 2 diabetes and persistent albuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAPS.2012.2

Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: the Di.N.A.S. randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAPS.2012.2

Rationale for and study design of the sulodexide trials in Type 2 diabetic, hypertensive patients with microalbuminuria or overt nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAPS.2012.2

Sulodexide suppresses inflammation in human endothelial cells and prevents glucose cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAPS.2012.2

Effect of sulodexide on aortic vasodilation capacity and associated morphological changes in rats with streptozotocin-induced diabetes

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4010349

Sulodexide improves endothelial dysfunction in streptozotocin-induced diabetes in rats.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4010349

Effect of oral treatment with the glycosaminoglycan sulodexide on peritoneal transport in CAPD patients.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4010349

Randomised, double blind, multicentre, placebo controlled study of sulodexide in the treatment of venous leg ulcers.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4010349

Glycosaminoglycan therapy prevents TGF-beta1 overexpression and pathologic changes in renal tissue of long-term diabetic rats.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4010349

A randomized, controlled study of sulodexide therapy for the treatment of diabetic nephropathy

31 October 2018

1 reference

https://api.crossref.org/works/10.1038%2FAPS.2012.2

Preliminary results of sulodexide treatment in patients with peripheral arteriosclerosis and hyperlipidemia. A multicentre trial

21 January 2018

1 reference

12 December 2020

Studies of chemical and biologic properties of a fraction of sulodexide, a heparin-like glycosaminoglycan

1 reference

12 December 2020

[Endothelial diseases and endothelium-protective agents]

1 reference

12 December 2020

Effect of sulodexide on albuminuria, NAG excretion and glomerular filtration response to dopamine in diabetic patients

1 reference

12 December 2020

Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease

1 reference

12 December 2020

Renoprotective effects of telmisartan in the 5/6 nephrectomised rats

1 reference

12 December 2020

The effect of glycosaminoglycan sulodexide on oxidative stress and fibrinolysis in diabetes mellitus

1 reference

12 December 2020

Evaluation of endothelium-protective effects of drugs in experimental models of endothelial damage

1 reference

12 December 2020

Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation

1 reference

12 December 2020

Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation

1 reference

12 December 2020

Effectiveness and tolerability of heparan sulfate in the treatment of superficial thrombophlebitis. Controlled clinical study vs sulodexide

1 reference

12 December 2020

Identifiers

DOI

10.1038/APS.2012.2

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference